Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c83 |
|---|---|
| Identifier | NCT06453317 |
| Trial Title | Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Inflammatory Bowel Diseases |
| Interventions | BIOLOGICAL: Infliximab|BIOLOGICAL: Ustekinumab |
Participant Information
| Sponsor | Medical University of Lodz |
|---|---|
| City | Łódź |
| Country/Region | Poland |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-07-24 |
|---|---|
| Primary Completion Date | 2028-04-30 |
| Completion Date | 2028-06-30 |